Protara Therapeutics, Inc.TARANASDAQ

Revenue (LTM)

Net Income (LTM)

$-57M

-28.8% YoY

Free Cash Flow

$-56M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	-0	0	-0
Operating Income	-47	-67↓41.2%	-44↑35.0%	-49↓12.7%	-65↓31.3%
Net Income	-47	-66↓39.6%	-40↑38.7%	-45↓10.3%	-57↓28.8%
EBITDA	-45	-65↓42.2%	-43↑33.0%	-49↓12.8%	-64↓31.5%
EPS Diluted	-4.20	-5.86↓39.5%	-3.57↑39.1%	-2.17↑39.2%	-1.34↑38.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	36	24↓32.5%	40↑64.1%	163↑311.3%	50↓69.5%
Total Current Assets	93	86↓7.5%	69↓20.2%	172↑150.6%	160↓7.3%
Total Assets	173	113↓34.4%	79↓30.3%	181↑129.8%	209↑15.4%
Total Current Liabilities	4	6↑33.6%	6↑7.1%	11↑78.3%	11↓0.2%
Total Liabilities	11	11↑4.9%	11↓5.1%	14↑34.7%	13↓8.8%
Total Equity	162	102↓37.0%	68↓33.1%	167↑144.6%	196↑17.5%
Total Debt	7	6↓11.8%	5↓14.4%	4↓18.0%	3↓25.1%
Net Debt	-28	-18↑37.7%	-34↓92.3%	-158↓364.0%	-46↑70.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-35	-26↑23.3%	-38↓42.0%	-36↑4.7%	-56↓57.4%
Capital Expenditure	-1	-0↑79.9%	-0↑62.5%	-0↓40.0%	-0↓49.2%
Free Cash Flow	-35	-27↑24.3%	-38↓41.5%	-36↑4.6%	-56↓57.4%
Stock-Based Comp	10	7↓35.5%	6↓8.9%	4↓32.3%	4↓7.2%
Net Change in Cash	-133	-12↑91.3%	15↑233.3%	123↑697.0%	-113↓191.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance